Showing results (1451-1460 of 1,497) with videos related to

Sort By:
Pageof 150
Journal of Biomedical Science|February 9, 2011
Functional characterization of Trip10 in cancer cell growth and survivalChia-Chen Hsu, Yu-Wei Leu, Min-Jen Tseng, et al.
Biochemical and Biophysical Research Communications|August 24, 2010
DNA methylation of the Trip10 promoter accelerates mesenchymal stem cell lineage determinationShu-Huei Hsiao, Kuan-Der Lee, Chia-Chen Hsu, et al.
Nanotechnology|December 7, 2023
High-performance monolayer MoS2nanosheet GAA transistorBo-Jhih Chou, Yun-Yan Chung, Wei-Sheng Yun, et al.
Plos Biology|March 19, 2019
Serotonin receptor HTR6-mediated mTORC1 signaling regulates dietary restriction-induced memory enhancementLing-Ling Teng, Guan-Ling Lu, Lih-Chu Chiou, et al.
Hepatology (Baltimore, Md.)|March 19, 2021
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse ModelYue Zhao, Jiaxu Wang, Wai Nam Liu, et al.
Nanoscale|October 22, 2024
Synergistic interfacial electronic modulation of topotactically developed bimetallic CoNiP on NiS nanorods for enhanced alkaline hydrogen evolution reactionWoldesenbet Bafe Dilebo, Meng-Che Tsai, Chia-Yu Chang, et al.
Annals of the Academy of Medicine, Singapore|January 31, 2025
Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experienceWei Sheng Joshua Loke, Jean Rachel Catapia, Chay Lee Low, et al.
The Journal of Biological Chemistry|May 8, 2012
58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathwayChe-Chia Hsu, Yi-Chao Lee, Shiu-Hwa Yeh, et al.
Trials|November 14, 2020
A study protocol for HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing cancer-related fatigue using TraditionAL Chinese Medicine: the HERBAL trialNing Yi Yap, Wei Sheng Loo, Huang Fang Zheng, et al.
Vaccine|June 24, 2015
Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trialTing Wu, Yue-Mei Hu, Juan Li, et al.
Pageof 150